Conduit Pharmaceuticals Inc (CDT) concluded trading on Wednesday at a closing price of $2.68, with 5.04 million shares of worth about $13.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -98.33% during that period and on June 04, 2025 the price saw a loss of about -17.03%. Currently the company’s common shares owned by public are about 0.63M shares, out of which, 0.34M shares are available for trading.
Stock saw a price change of -27.37% in past 5 days and over the past one month there was a price change of -64.44%. Year-to-date (YTD), CDT shares are showing a performance of -97.40% which decreased to -99.94% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.03 but also hit the highest price of $4680.00 during that period. The average intraday trading volume for Conduit Pharmaceuticals Inc shares is 247.69K. The stock is currently trading -44.32% below its 20-day simple moving average (SMA20), while that difference is down -66.74% for SMA50 and it goes to -97.12% lower than SMA200.
Conduit Pharmaceuticals Inc (NASDAQ: CDT) currently have 0.63M outstanding shares and institutions hold larger chunk of about 4.54% of that.
The stock has a current market capitalization of $2.02M and its 3Y-monthly beta is at 2.00. It has posted earnings per share of -$266.45 in the same period. It has Quick Ratio of 1.31 while making debt-to-equity ratio of 1.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CDT, volatility over the week remained 18.30% while standing at 9.93% over the month.
